(R)-1-Benzyl 4-tert-butyl 2-(aminomethyl)piperazine-1,4-dicarboxylate

Catalog No. :
ACXHMI978
CAS No. :
1212316-00-1
Molecular Formula :
C18H27N3O4
Molecular Weight :
349.43

IUPAC Name:1-benzyl 4-(tert-butyl) (R)-2-(aminomethyl)piperazine-1,4-dicarboxylate

(R)-1-Benzyl 4-tert-butyl 2-(aminomethyl)piperazine-1,4-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-Benzyl 4-tert-butyl 2-(aminomethyl)piperazine-1,4-dicarboxylate
IUPAC Name1-benzyl 4-(tert-butyl) (R)-2-(aminomethyl)piperazine-1,4-dicarboxylate
MDL No.MFCD09971768
Molecular FormulaC18H27N3O4
Molecular Weight349.43
SMILESO=C(N1[C@H](CN)CN(C(OC(C)(C)C)=O)CC1)OCC2=CC=CC=C2
InChI KeyUPAFWAIJOIWWEZ-OAHLLOKOSA-N
Synonym(R)-1-BENZYL 4-TERT-BUTYL 2-(AMINOMETHYL)PIPERAZINE-1,4-DICARBOXYLATE;R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine;1,4-Piperazinedicarboxylic acid, 2-(aminomethyl)-, 4-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (2R)-;1-Benzyl 4-(tert-butyl) (R)-2-(aminomethyl)piperazine-1,4-dicarboxylate;(R)-4-Boc-1-Cbz-2-(aminomethyl)piperazine
CAS No.1212316-00-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXHMI978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHMI978 route product structure diagram
    ACXHMI9781212316-00-1
Inquiry

2. ACXHMI978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHMI978 route product structure diagram
    ACXHMI9781212316-00-1
Inquiry

Comments (0)